Tag: Baroness Gale

  • Baroness Gale – 2016 Parliamentary Question to the Department of Health

    Baroness Gale – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Gale on 2016-04-19.

    To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 April (HL7369), when the policy team is expected to report back on key aspects of the work on neurology and how those aspects can be taken forward through alternative mechanisms and partners; and whether or not that report will be published.

    Lord Prior of Brampton

    As previously set out, NHS England has been reviewing its National Clinical Director (NCD) resource. This review has been designed to focus clinical advisory resources on areas where major programmes of work are currently being taking forward, or areas identified as priorities for improvement.

    Whilst there will no longer be a specific NCD role for neurology, NHS England will continue to secure expert clinical advice through clinical leads and members of the NHS England-funded neurology clinical networks, the Neurology Clinical Reference Group and Royal Colleges.

    More information on these arrangements will be available in June 2016. There is no specific report being published.

  • Baroness Gale – 2016 Parliamentary Question to the Ministry of Justice

    Baroness Gale – 2016 Parliamentary Question to the Ministry of Justice

    The below Parliamentary question was asked by Baroness Gale on 2016-01-21.

    To ask Her Majesty’s Government how many (1) prosecutions, and (2) convictions, there have been in Wales under section 53A of the Sexual Offences Act 2003 in each year since 2010, and what penalty was imposed in each case.

    Lord Faulks

    There were no prosecutions brought under section 53A of the Sexual Offences Act 2003, in Wales, from 2010 to 2014 (the latest available).

    Data on court proceedings for calendar year 2015 is planned for publication in May 2016.

  • Baroness Gale – 2016 Parliamentary Question to the Department of Health

    Baroness Gale – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Gale on 2016-03-23.

    To ask Her Majesty’s Government what assessment they have made of the impact on the NHS of NHS England cutting the role of National Clinical Director for Adult Neurology, and the end of national funding for neurological work by clinical networks.

    Lord Prior of Brampton

    Sir Bruce Keogh, NHS England’s Medical Director, has undertaken a review of the National Clinical Director (NCD) resource designed to focus clinical advisory resources on areas where major programmes of work are currently being taking forward, or areas identified as priorities for improvement. As a result of the review, NHS England has proposed to change the way in which clinical advice is received in speciality areas in the future, streamlining and strengthening its clinical advisory mechanisms in support of the Five Year Forward View and the National Health Service’s key improvement priorities.

    Whilst there will no longer be a specific NCD role for neurology, NHS England will continue to secure expert clinical advice from its Clinical Networks and through its relationships with professional bodies and by appointing clinical advisors. Access to advice will be through clinical leads and members of the NHS England-funded neurology clinical networks, the Neurology Clinical Reference Group and Royal Colleges. It is expected that these new arrangements will be in place shortly.

    During 2016/17, the focus of NHS England’s improvement efforts delivered through Strategic Clinical Networks will be on a smaller range of key national priorities, including cancer, mental health, diabetes, maternity and urgent and emergency care (with a focus on cardiovascular disease transformation). Whilst there is no additional funding nationally, clinical and local networks of care can determine what can be done at a local or regional level if it is considered a local or regional system priority. Nationally, the policy team is considering how key aspects of the work on neurology can be taken forward through alternative mechanisms and partners.

    In addition, the Neurology Intelligence Network (NIN) is a joint partnership programme between Public Health England (PHE) and NHS England to support the generation and dissemination of neurology related health intelligence. PHE currently funds the on-going design, development and management of the NIN.

  • Baroness Gale – 2016 Parliamentary Question to the Department of Health

    Baroness Gale – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Gale on 2016-03-23.

    To ask Her Majesty’s Government what assessment they have made of the impact on the NHS of NHS England cutting the role of National Clinical Director for Adult Neurology, and the end of national funding for neurological work by clinical networks.

    Lord Prior of Brampton

    Sir Bruce Keogh, NHS England’s Medical Director, has undertaken a review of the National Clinical Director (NCD) resource designed to focus clinical advisory resources on areas where major programmes of work are currently being taking forward, or areas identified as priorities for improvement. As a result of the review, NHS England has proposed to change the way in which clinical advice is received in speciality areas in the future, streamlining and strengthening its clinical advisory mechanisms in support of the Five Year Forward View and the National Health Service’s key improvement priorities.

    Whilst there will no longer be a specific NCD role for neurology, NHS England will continue to secure expert clinical advice from its Clinical Networks and through its relationships with professional bodies and by appointing clinical advisors. Access to advice will be through clinical leads and members of the NHS England-funded neurology clinical networks, the Neurology Clinical Reference Group and Royal Colleges. It is expected that these new arrangements will be in place shortly.

    During 2016/17, the focus of NHS England’s improvement efforts delivered through Strategic Clinical Networks will be on a smaller range of key national priorities, including cancer, mental health, diabetes, maternity and urgent and emergency care (with a focus on cardiovascular disease transformation). Whilst there is no additional funding nationally, clinical and local networks of care can determine what can be done at a local or regional level if it is considered a local or regional system priority. Nationally, the policy team is considering how key aspects of the work on neurology can be taken forward through alternative mechanisms and partners.

    In addition, the Neurology Intelligence Network (NIN) is a joint partnership programme between Public Health England (PHE) and NHS England to support the generation and dissemination of neurology related health intelligence. PHE currently funds the on-going design, development and management of the NIN.

  • Baroness Gale – 2014 Parliamentary Question to the Department of Health

    Baroness Gale – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Gale on 2014-06-09.

    To ask Her Majesty’s Government what steps they are taking to ensure that clinicians making Individual Funding Requestsfor the prescription of Duodopa to people with Parkinson’s are informed of the outcome within 40 days.

    Earl Howe

    From April 2013, NHS England assumed responsibility for commissioning adult specialist neurosciences services, including the majority of services for patients with Parkinson’s disease, with some being the responsibility of clinical commissioning groups.

    NHS England has advised that it does not routinely fund Duodopa (co-careldopa) for the treatment of Parkinson’s disease. Clinicians can submit individual funding requests for this treatment on behalf of their patients as per NHS England’s individual funding requests standard operating procedure, which is at:

    www.england.nhs.uk/wp-content/uploads/2013/04/cp-04.pdf

    NHS England has advised that its individual funding request process is monitored against the standard operating procedure to ensure that referring clinicians are informed of outcomes in a timely manner.

  • Baroness Gale – 2014 Parliamentary Question to the Department of Health

    Baroness Gale – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Gale on 2014-06-09.

    To ask Her Majesty’s Government what steps they are taking to ensure that recommendations by the Clinical Priorities Advisory Group on theprescription of Duodopa for people with Parkinson’s have been developed with public and patient engagement.

    Earl Howe

    The operation of the Clinical Priorities Advisory Group (CPAG) is a matter for NHS England. NHS England has advised that the CPAG is chaired by a lay member and has four public members as part of its core membership.

    The draft policy on Duodopa was developed by the Neurosciences Clinical Reference Group, which has four patient/carer members. Registered patient and public stakeholders had an opportunity to share their views and comment on this draft policy before it was considered by CPAG.

    CPAG has made recommendations to NHS England. NHS England’s decision on whether Duodopa should be routinely commissioned will be subject to 12 weeks public consultation.

  • Baroness Gale – 2014 Parliamentary Question to the Home Office

    Baroness Gale – 2014 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Baroness Gale on 2014-06-17.

    To ask Her Majesty’s Government what discussions they have had with police forces in England and Wales and with the Football Association of England in order to counter any rise in domestic violence while England are playing in the World Cup 2014; and what steps they are taking to ensure that police forces and supporting agencies are fully resourced to deal with the matter.

    Lord Taylor of Holbeach

    Domestic abuse is an abhorrent crime and the Coalition Government is committed to ending it whenever it occurs.

    Together with the police, we are supporting the Football United Against Domestic Abuse campaign by Women’s Aid, the launch of which was attended by the Crime Prevention Minister and supported by the Home Secretary. This campaign is working with the football community to unite players, clubs and fans at all levels against behaviour and attitudes that underpin domestic abuse.

    The Crime Prevention Minister intends to meet with footballing interests in the near future to build on this campaign.

    As part of its commitment to tackle domestic abuse, the Government is re-running a campaign to highlight the devastating consequences of domestic abuse for perpetrators of domestic abuse. The campaign was launched on 9 June and activity will run throughout the World Cup until 14 July 2014. Through posters and digital adverts, this campaign will target potential perpetrators and remind them of the terrible impact of violence on relationships.

    Additional support to victims of domestic abuse is available through specialist local domestic abuse services and the national domestic violence helplines. The CoalitionGovernment has ring-fenced nearly £28 million of funding up to 2015 to support these services, which includes part-funding 144 Independent Domestic Violence Advisors and 54 Multi-Agency Risk Assessment Conference co-ordinator posts.